Optimizing therapeutics for hospitalized patients with impaired renal function
Optimizing therapeutics for hospitalized patients with impaired renal function
批准号:
7132855
负责人:
Joseph F. Peterson
金额:
$7.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2008-08-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
A third of patients admitted to the hospital have underlying renal impairment or develop acute renal failure during their hospital course. The majority of these patients are prescribed a drug that is sensitive to renal function, and should be dose adjusted to avoid drug accumulation and toxicity. Over three decades of research has produced a variety of techniques to estimate renal clearance and other pharmacokinetic parameters which can instruct prescribers on how to adjust doses or frequencies of administration. However, few of these techniques are reliably applied by physicians or other providers, and inaccurate dosing in the setting of renal insufficiency has been identified as one of the major causes of preventable adverse drug events.
Computerized prescriptions with automated guidance for prescribers will ultimately provide the safeguards and real-time assistance that is needed to prevent dosing errors. However, the existing implementations may not be sophisticated enough to offer accurate dosing recommendations. For example, the widely used Cockcroft-Gault estimate for renal clearance is inaccurate at the extremes of weight and age and with rapid changes in kidney function. All of these caveats are frequently present in hospitalized patients. It is unknown how many of the drug recommendations generated by a 'single-model1 approach would be altered if a more tailored, individualized approach was applied. We hypothesize that 3 major changes to a renal dose decision support system will substantially alter the guidance: 1) estimate drug clearance with a model tailored to patient characteristics 2) notification of changes to drug clearance which should alter existing drug therapy 3) apply medication-specific pharmacokinetic models to dose therapies with a narrow therapeutic range. We will test our hypothesis by simulating the performance of each redesigned component in a large dataset of patient and prescription data.
Relevance to public health: Hospitalized patients with impaired kidney function need special care and monitoring to avoid drug accumulation and direct kidney toxicity. Computerized systems of care are needed to optimally assist with drug dosing and to assist physicians with maintaining vigilance when sudden changes in health status make prior drug dosing obsolete.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Electronic Medical Records and Genomics (eMERGE) Network Phase III - Coordinating Center (U01)
-
批准号:10164633
-
项目类别:
-
资助金额:$90.04万
-
财政年份:2020
-
负责人:Joseph F. Peterson
-
依托单位:
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
-
批准号:10215587
-
项目类别:
-
资助金额:$58.06万
-
财政年份:2018
-
负责人:Joseph F. Peterson
-
依托单位:
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
-
批准号:9788502
-
项目类别:
-
资助金额:$41.15万
-
财政年份:2018
-
负责人:Joseph F. Peterson
-
依托单位:
The Electronic Medical Records and Genomics (eMERGE) Network Phase III - Coordinating Center (U01)
-
批准号:9134806
-
项目类别:
-
资助金额:$96.63万
-
财政年份:2015
-
负责人:Joseph F. Peterson
-
依托单位:
Information Systems for Detecting and Managing Acute Kidney Injury
-
批准号:7689828
-
项目类别:
-
资助金额:$33.39万
-
财政年份:2008
-
负责人:Joseph F. Peterson
-
依托单位:
Information Systems for Detecting and Managing Acute Kidney Injury
-
批准号:7925794
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2008
-
负责人:Joseph F. Peterson
-
依托单位:
Optimizing therapeutics for hospitalized patients with impaired renal function
-
批准号:7282350
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2006
-
负责人:Joseph F. Peterson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
BRPF1 m6A修饰异常通过重塑BCAT1超级增强子介导Setd2缺陷型肾癌支链氨基酸代谢成瘾的机制研究
-
批准号:82372724
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:何竑超
-
依托单位:
DACH1对糖尿病肾病足细胞脂质代谢的调控作用和机制研究
-
批准号:82370719
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹爱丽
-
依托单位:
Kidney injury molecular(KIM-1)介导肾小管上皮细胞自噬在糖尿病肾病肾间质纤维化中的作用
-
批准号:81300605
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:唐琳
-
依托单位:
生物标志物NGAL和KIM-1分子在急性肾损伤中的作用机制研究及标志物联合检测对早期诊断AKI的作用
-
批准号:81101308
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:李海霞
-
依托单位:
肠上皮内γδT细胞诱导抗原特异性Treg的体内机制及其对肾移植慢性排斥的抑制作用研究
-
批准号:81170693
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:黄赤兵
-
依托单位:
血管内皮生长抑制因子对肾透明细胞癌微血管形成和肿瘤生长的影响
-
批准号:81072088
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:张宁
-
依托单位:
钙激活的大电流钾离子通道β1亚基影响慢性肾脏病进展的机制探讨
-
批准号:81070587
-
项目类别:面上项目
-
资助金额:38.0万元
-
批准年份:2010
-
负责人:陈育青
-
依托单位:
缺氧预处理调节骨髓源性间充质干细胞归巢能力对兔急性缺血性肾损伤修复的影响
-
批准号:81000307
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:俞小芳
-
依托单位:
肾损伤分子-1介导肾小管上皮细胞吞噬作用的病生理意义及机制研究
-
批准号:81070549
-
项目类别:面上项目
-
资助金额:37.0万元
-
批准年份:2010
-
负责人:杨莉
-
依托单位:
HIF-1α和2α在肾脏晚期缺血预适应中的作用及相关功能基因的研究
-
批准号:30871176
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:丁小强
-
依托单位: